Multiple sclerosis: open trials in Slovakia

12 open trials have a site in Slovakia. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
MUDr. Beata Dupejova, Neurologicka Ambulancia S.r.o., Banská Bystrica · University Hospital Bratislava, Bratislava · Univerzitna nemocnica Martin, Martin · Fakultna nemocnica s poliklinikou J.A. Reimana Presov, Prešov
Registry updated 2026-11-03
NCT07220252
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Trial Treatment · Phase 2/3 · TG Therapeutics, Inc.
Narodny ustav detskych chorob, Bratislava
Registry updated 2026-10-29
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
Univerzitna nemocnica Martin, Martin · Fakultna Nemocnica Nitra, Nitra · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
University Hospital Bratislava, Bratislava · Fakultna nemocnica s poliklinikou J.A. Reimana Presov, Prešov · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-10-27
NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
University Hospital Bratislava, Bratislava · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-10-26
2024-512914-16-00
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Amgen Inc.
University Hospital Bratislava, Bratislava · Empathy s.r.o., Bratislava · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Bratislava · Novartis Investigative Site, Komárno · Novartis Investigative Site, Nitra · Novartis Investigative Site, Trnava
Registry updated 2026-10-13
2024-511686-11-00
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Narodny ustav detskych chorob, Bratislava
Registry updated 2026-09-29
NCT07786506
Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis
Trial Treatment · Comenius University
2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava and University Hospital Bratislava, Bratislava
Registry updated 2026-08-26
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Empathy s.r.o., Bratislava · University Hospital Bratislava, Bratislava · Nemocnica AGEL Komarno s.r.o., Komarno · Fakultna Nemocnica Nitra, Nitra · Fakultna nemocnica Trnava, Trnava
Registry updated 2026-07-30
NCT07025122
Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease
Research · University Hospital, Martin
University Hospital in Martin, Comenius University, Martin
Registry updated 2025-06-17
NCT01444833
Effects of GLP-1 analogue in multiple sclerosis
Trial Treatment · Phase 2 · Comenius University Bratislava
Comenius University Bratislava, Bratislava
Registry updated 2024-11-07

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error